Stem Cell Therapy - A Solution for Parkinson's disease

LA JOLLA, Calif., Oct. 23, 2013 /PRNewswire/ -- "Stem cell therapy is an enthralling new achievement for the management of Parkinson's disease," said Dr. Stacy, the Vice Dean for Clinical Research, Neurology at Duke University School of Medicine.

According to the Michael J. Fox Foundation, Parkinson's disease in the U.S. alone affects one in 100 people over 60 and 60,000 new cases will be diagnosed this year. Additionally, today's best Parkinson's drug was discovered in 1967.

Fast forward to 2013, stem cells offer a window into brain degenerating Parkinson's disease (PD). Scientists have found stem cells to be especially promising for treating rapidly-progressing diseases. Current findings propose that stem cells are appropriate in the management of neurodegenerative disorders.

Adipose-derived adult stem (ADAS) cells are the multipotent cells and precursors for the important cells of the central nervous system. Researchers have found that these stem cells self-renew and provide a therapeutic effect by differentiating into dopaminergic neurons and expressing neurotrophic factors e.g. brain-derived neurotrophic factor (BDNF) and glial derived neurotrophic factor (GDNF). All these facilitate protection of the nigrostriatal system thus offering a revolutionary and new prospect for the treatment of Parkinson's disease, particularly in cases where existing dopamine-replacement approaches remain unsuccessful to satisfactorily combat the symptoms.  (PD is the result of loss of dopamine-generating cells in the nigrostriatal system).

Kitada M and Dezawa M, the two prominent researchers of Tohoku University Graduate School of Medicine, Sendai, Japan, noted that cell transplantation holds a great potential for treating Parkinson's disease, and numerous other diseases. According to them, the stem cells are easily accessible and are devoid of serious technical and ethical problems and are the appropriate candidates for transplantation.  Stem cell therapy is a unique way to repair or replace the damaged or dead cells in the disease process, and re-establish cell function and alleviate symptoms.  Thus, such cells may bring about improvement in clinical manifestations of neurodegenerative diseases and neural injuries.

StemGenex® a leading independent U.S. based company has observed researcher's findings to be accurate while working with patients diagnosed with Parkinson's disease. StemGenex provides access to promising treatment for Parkinson's disease via adipose-derived stem cells.  The majority of patients with PD who have undergone this therapy are progressively reporting a reduction of their symptoms and improvement of their quality of living.

StemGenex® is recognized for its service to health, including its function in laying the basis for innovative treatments for Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, Autoimmune diseases, and COPD. It is determined on providing the therapeutic applications of stem cells. New studies and clinical trials are under consideration by the company for the human well-being and health.

To find out more information on adipose stem cell treatments for Parkinson's disease contact StemGenex at 800-609-7795.

[email protected]

http://www.StemGenex.com

Related Links:
Stem Cell Treatments 
Contact StemGenex

Video with caption: "Stem Cell Therapy - A Solution For Parkinson's Disease A Computer Graphic visualization of a Brain cell synapse showing chemical messengers or neurotransmitters released from pre-synaptic neuron to be received by the post-synaptic nerve cell receptor." Video available at:  http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/FX-MM02678-20131023-03.mp4 

Image with caption: "Adipose-derived adult stem (ADAS) cells are the multipotent cells and precursors for the important cells of the central nervous system. Researchers have found that these stem cells self-renew and provide a therapeutic effect by differentiating into dopaminergic neurons and expressing neurotrophic factors e.g. brain-derived neurotrophic factor (BDNF) and glial derived neurotrophic factor (GDNF). All these facilitate protection of the nigrostriatal system thus offering a revolutionary and new prospect for the treatment of Parkinson's disease, particularly in cases where dopamine-replacement approaches remain unsuccessful to satisfactorily combat the symptoms. (PD is the result of loss of dopamine-generating cells in the nigrostriatal system)." Image available at: http://photos.prnewswire.com/prnh/20131023/MM02678-a

Image with caption: "What is Parkinson's Disease? Parkinson's disease is a chronic progressive neurological disease that affects nerve cells (neurons) in an area of the brain known as the substantia nigra. When healthy these cells normally produce dopamine, a chemical (neurotransmitter) which transmits signals between areas in the brain. This chemical coordinates smooth and balanced muscle movement. Parkinson's disease causes these nerve cells to die, and as a result, body movements are affected." Image available at: http://photos.prnewswire.com/prnh/20131023/MM02678-b

SOURCE StemGenex